ANDREA MACY-STURGIS: Open Payments
NPI 1619515186 · MERRIAM, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 26 payments from 5 companies in 2025. Trend: 2023 $269 · 2024 $248 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $279 |
| GENZYME CORPORATION | 9 | $189 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $19 |
Products named: NUCALA, DUPIXENT, XHANCE, UBRELVY.
Industry payments across KS — which companies pay providers there.
